Some Recalled Infants’ Tylenol Had Too Much Acetaminophen

Alexis Brekke Pellek PharmTech editorThe Wall Street Journal reported yesterday that some of McNeil Consumer Healthcare’s recalled infants’ Tylenol contained as much as 24% more acetaminophen than it should have, according to a letter the company sent to physicians and poison-control personnel. McNeil’s letter stated that the samples containing the 24% increase did not reach the public, but that the company could not be sure “all the individual bottles were within specification or that 24% would have been the maximum,” according to WSJ. Read more »

Dark Horse or Albatross?

Erik Greb PharmTech editorReading the news sometimes gives me a disorienting sense of déjà vu. I felt it again when I read that Ranbaxy (Gurgaon, Haryana, India) had recalled a batch of its acne drug isotretinoin after the US Food and Drug Administration found that the product’s dissolution-test results were out of specification. Didn’t this happen once before? Read more »

Double Whammy for Actavis

Erik Greb PharmTech editorThe US Department of Justice (DOJ) is seeking a permanent injunction to prevent Actavis Totowa (Totowa, NJ) and Actavis (Hafnarfjordur, Iceland), its parent company, from manufacturing and distributing generic drugs. The government is taking this dramatic step after the company repeatedly violated good manufacturing practice (GMP). Read more »

Heparin Crisis Leaves Pharma Bleeding

Maribel rios PharmTech editorAs a law in my state, drivers are not “allowed” to pump their own gas. I suppose it has helped the Oregon economy with providing additional (read: low wage) jobs. In turn, our gas taxes may be a little higher than the rest of the country’s. Last week, however, as I pulled up to take another hit to the family budget with another fill-up, I noticed a sign at the station declaring “diesel customers: you are responsible for making sure the right gas is pumped into your vehicle.” Read more »

« Previous Page